COVID-19 and Dengue Co-epidemic during the Second Wave of the Pandemic in Bangladesh: A Double Blow for an Overburdened Health-Care System

Abstract

We have recently reported a global review of vaccine effectiveness (VE) data evaluating almost 80 real-world studies [Citation1]. At the time of data extraction (10 February 2022), the vast majority of studies were limited to two-dose primary vaccination schedules and were predominantly conducted before the emergence of the Omicron variants. To address gaps in the data relating to VE against the Omicron variant, and significantly after the use of booster doses, we have already begun to evaluate a more recent data cut and hope to be able to share that analysis soon...